GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CellaVision AB (OSTO:CEVI) » Definitions » Equity-to-Asset

CellaVision AB (OSTO:CEVI) Equity-to-Asset : 0.78 (As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is CellaVision AB Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. CellaVision AB's Total Stockholders Equity for the quarter that ended in Mar. 2024 was kr758.8 Mil. CellaVision AB's Total Assets for the quarter that ended in Mar. 2024 was kr974.1 Mil. Therefore, CellaVision AB's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.78.

The historical rank and industry rank for CellaVision AB's Equity-to-Asset or its related term are showing as below:

OSTO:CEVI' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.54   Med: 0.76   Max: 0.83
Current: 0.78

During the past 13 years, the highest Equity to Asset Ratio of CellaVision AB was 0.83. The lowest was 0.54. And the median was 0.76.

OSTO:CEVI's Equity-to-Asset is ranked better than
71.48% of 873 companies
in the Medical Devices & Instruments industry
Industry Median: 0.64 vs OSTO:CEVI: 0.78

CellaVision AB Equity-to-Asset Historical Data

The historical data trend for CellaVision AB's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellaVision AB Equity-to-Asset Chart

CellaVision AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.54 0.64 0.66 0.72 0.77

CellaVision AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.74 0.73 0.76 0.77 0.78

Competitive Comparison of CellaVision AB's Equity-to-Asset

For the Medical Devices subindustry, CellaVision AB's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CellaVision AB's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CellaVision AB's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where CellaVision AB's Equity-to-Asset falls into.



CellaVision AB Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

CellaVision AB's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=716.389/928.712
=0.77

CellaVision AB's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=758.762/974.116
=0.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CellaVision AB  (OSTO:CEVI) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


CellaVision AB Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of CellaVision AB's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


CellaVision AB (OSTO:CEVI) Business Description

Traded in Other Exchanges
Address
Mobilvagen 12, Lund, SWE, 22362
CellaVision AB is engaged in the business of supplying digital solutions for blood and body fluid analysis. Its solutions are based on digital image analysis technology, artificial intelligence, and information technology. The firm's product portfolio consists of CellaVision peripheral blood application, CellaVision advanced RBC application, and CellaVision remote review software. Its customers include mainly large hospital laboratories and commercial laboratories in North America, Europe and China, and Japan. The company derives the majority of its revenue from the sale of analyzers.

CellaVision AB (OSTO:CEVI) Headlines

No Headlines